The role of thalidomide in dermatology

被引:6
|
作者
Hussain, K. [1 ]
Patel, P. [1 ]
Roberts, N. [1 ]
机构
[1] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Dermatol, London, England
关键词
NECROBIOTIC XANTHOGRANULOMA; THERAPY; LENALIDOMIDE; NEUROPATHY; PATIENT; LESIONS;
D O I
10.1111/ced.15019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Thalidomide is a medication that has been in existence for over half a century, and has proven to be useful and effective in severe dermatological conditions. For dermatologists, the ability of thalidomide to reduce the levels of the cytokine tumour necrosis factor-alpha, along with its immunomodulatory and anti-angiogenic properties, is of great significance, with the added advantage of being an oral medication. Its use is of course strictly monitored, owing to its potential adverse effects (AEs), particularly teratogenicity, with precautions taken to ensure its safe and correct use by both prescriber and patient. In this review, we look at the background and mechanism of action of thalidomide, provide an overview of conditions it can be used for with case examples, explain the potential AEs and monitoring requirements, and discuss future developments.
引用
收藏
页码:667 / 674
页数:8
相关论文
共 50 条
  • [41] Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model
    Zhu, Wan
    Chen, Wanqiu
    Zou, Dingquan
    Wang, Liang
    Bao, Chen
    Zhan, Lei
    Saw, Daniel
    Wang, Sen
    Winkler, Ethan
    Li, Zhengxi
    Zhang, Meng
    Shen, Fanxia
    Shaligram, Sonali
    Lawton, Michael
    Su, Hua
    STROKE, 2018, 49 (05) : 1232 - +
  • [42] A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis
    Lim, Victoria M.
    Maranda, Eric L.
    Patel, Vivek
    Simmons, Brian J.
    Jimenez, Joaquin J.
    DERMATOLOGY AND THERAPY, 2016, 6 (03) : 397 - 411
  • [43] Attainment of a Stringent Complete Response in Multiple Myeloma with Thalidomide Monotherapy
    Aritaka, Nanae
    Ichikawa, Kunimoto
    Nakamura, Hiroko
    Yasuda, Hajime
    Ogura, Kanako
    Matsumoto, Toshiharu
    Komatsu, Norio
    Hirano, Takao
    INTERNAL MEDICINE, 2012, 51 (19) : 2781 - 2783
  • [44] Thalidomide for POEMS syndrome
    So Yeon Kim
    Sun Ah Lee
    Hun Mo Ryoo
    Kyung Hee Lee
    Myung Soo Hyun
    Sung Hwa Bae
    Annals of Hematology, 2006, 85 : 545 - 546
  • [45] Treatment of multiple myeloma with immunomodulatory drugs - thalidomide, lenalidomide and pomalidomide
    Rzepecki, Piotr
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (05): : 265 - 275
  • [46] Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms
    Domingo, Sandra
    Sole, Cristina
    Molin, Teresa
    Ferrer, Berta
    Ordi-Ros, Josep
    Cortes-Hernandez, Josefina
    DERMATOLOGY, 2020, 236 (05) : 467 - 476
  • [47] Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone
    Du, Juan
    Yuan, Zhengang
    Zhang, Chunyang
    Fu, Weijun
    Jiang, Hua
    Chen, Baoan
    Hou, Jian
    LEUKEMIA RESEARCH, 2010, 34 (11) : 1453 - 1458
  • [48] Pentoxifylline in dermatology
    Balazic, Eliza
    Axler, Eden
    Konisky, Hailey
    Khanna, Urmi
    Kobets, Kseniya
    JOURNAL OF COSMETIC DERMATOLOGY, 2023, 22 (02) : 410 - 417
  • [49] Leflunomide in dermatology
    Boyd, Alan S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : 673 - 679
  • [50] Phenomena in dermatology
    Madke, Bhushan
    Doshi, Bhavana
    Pande, Sushil
    Khopkar, Uday
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2011, 77 (03): : 264 - 275